MicroRNAs in Cancer: Challenges and Opportunities in Early Detection, Disease Monitoring, and Therapeutic Agents
Current Pathobiology Reports · 2017-03 · 5 (1) · 35-42
DOI: 10.1007/s40139-017-0123-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Pathobiology Reports, online erschienen am 19.01.2017. Verfasst von Namita Chatterjee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell, Development and Cancer Biology, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
PURPOSE OF REVIEW: The goals of this review are to examine the usefulness of miRNAs as diagnostic and prognostic biomarkers for cancer and to evaluate the applicability of miRNAs as cancer therapeutics. RECENT FINDINGS: Examination of miRNA milieu from body fluids offers a new alternative for quick, affordable and easy analysis of disease status in patients. Blood-based exosomal miRNAs have increased stability and are an excellent choice for clinical cancer diagnostics and prognostics. Currently, there are many miRNA signatures associated with cancer and progression but there is no consensus among multiple sera and tumor sample studies. Off-target and immunological effects remains an obstacle for use of miRNAs as novel chemotherapeutics in the clinic. Recent developments in nanotechnology and drug delivery systems which target the tumor microenvironment may provide an alternative therapeutic approach with decreased toxicity. SUMMARY: This review critically evaluates the literature investigating the use of miRNAs as biomarkers and their future as potential therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cell, Development and Cancer Biology, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239.
- Department of Radiation Medicine, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Chatterjee, N., Rana, S., Espinosa-Diez, C., & Anand, S. (2017). MicroRNAs in Cancer: Challenges and Opportunities in Early Detection, Disease Monitoring, and Therapeutic Agents. Current Pathobiology Reports, 5(1), 35-42. https://doi.org/10.1007/s40139-017-0123-0
Vancouver
Chatterjee N, Rana S, Espinosa-Diez C, Anand S. MicroRNAs in Cancer: Challenges and Opportunities in Early Detection, Disease Monitoring, and Therapeutic Agents. Current Pathobiology Reports. 2017;5(1):35-42. doi:10.1007/s40139-017-0123-0
BibTeX
@article{Chatterjee2017,
author = {Chatterjee, Namita and Rana, Shushan and Espinosa-Diez, Cristina and Anand, Sudarshan},
title = {MicroRNAs in Cancer: Challenges and Opportunities in Early Detection, Disease Monitoring, and Therapeutic Agents},
journal = {Current Pathobiology Reports},
year = {2017},
volume = {5},
number = {1},
pages = {35--42},
doi = {10.1007/s40139-017-0123-0}
}
EUVIMED